{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:12:39Z","timestamp":1792559559462,"version":"4.5.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2019MB017"],"award-info":[{"award-number":["ZR2019MB017"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116972","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T01:12:09Z","timestamp":1729127529000},"page":"116972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["HDAC8 as a target in drug discovery: Function, structure and design"],"prefix":"10.1016","volume":"280","author":[{"given":"Qianlong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqian","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3202-1733","authenticated-orcid":false,"given":"Jingde","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116972_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116972_bib2","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.3390\/cells11193161","article-title":"Pathological role of HDAC8: cancer and beyond","volume":"11","author":"Kim","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2024.116972_bib3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4155\/fmc-2016-0117","article-title":"Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases","volume":"8","author":"Chakrabarti","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib4","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJMra1402513","article-title":"The key role of epigenetics in human disease prevention and mitigation","volume":"378","author":"Feinberg","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116972_bib5","doi-asserted-by":"crossref","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejmech.2024.116972_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1139\/o05-041","article-title":"Role of histone acetylation in the control of gene expression","volume":"83","author":"Verdone","year":"2005","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.ejmech.2024.116972_bib7","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib8","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1002\/anie.200461346","article-title":"Epigenetics\u2014an epicenter of gene regulation: histones and histone-modifying enzymes","volume":"44","author":"Biel","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.116972_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2024.116972_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101312","article-title":"HDAC inhibitors: targets for tumor therapy, immune modulation and lung diseases","volume":"16","author":"Shanmugam","year":"2022","journal-title":"Translational Oncology"},{"key":"10.1016\/j.ejmech.2024.116972_bib11","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acs.jmedchem.0c01676","article-title":"Dissecting histone deacetylase 3 in multiple disease conditions: selective inhibition as a promising therapeutic strategy","volume":"64","author":"Adhikari","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejmech.2018.12.039","article-title":"Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: an overview","volume":"164","author":"Banerjee","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib13","article-title":"Histone deacetylase complexes: structure, regulation and function","volume":"1879","author":"Asmamaw","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejmech.2024.116972_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2024.116972_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113946","article-title":"Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)","volume":"227","author":"He","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/bib\/bbt060","article-title":"Systematic identification of Class I HDAC substrates","volume":"15","author":"Li","year":"2014","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.ejmech.2024.116972_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2015.04.013","article-title":"HDAC8: a multifaceted target for therapeutic interventions","volume":"36","author":"Chakrabarti","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2024.116972_bib18","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116972_bib19","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4155\/fmc-2017-0130","article-title":"Structure-activity relationships of hydroxamate-based histone deacetylase-8 inhibitors: reality behind anticancer drug discovery","volume":"9","author":"Amin","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/13543776.2024.2391289","article-title":"A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present)","author":"Banerjee","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2024.116972_bib21","doi-asserted-by":"crossref","first-page":"10000","DOI":"10.1021\/acs.jmedchem.8b01087","article-title":"Characterization of histone deacetylase 8 (HDAC8) selective inhibition reveals specific active site structural and functional determinants","volume":"61","author":"Marek","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/948319","article-title":"NBM-T-L-BMX-OS01, semisynthesized from osthole, is a novel inhibitor of histone deacetylase and enhances learning and memory in rats","volume":"2013","author":"Yang","year":"2013","journal-title":"Evid. base Compl. Alternative Med."},{"key":"10.1016\/j.ejmech.2024.116972_bib23","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.3390\/ijms22115907","article-title":"NBM-BMX, an HDAC8 inhibitor, overcomes temozolomide resistance in glioblastoma multiforme by downregulating the \u03b2-Catenin\/c-Myc\/SOX2 pathway and upregulating p53-mediated MGMT inhibition","volume":"22","author":"Tsai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116972_bib24","doi-asserted-by":"crossref","first-page":"15254","DOI":"10.1074\/jbc.M908988199","article-title":"Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor","volume":"275","author":"Hu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj3500199","article-title":"Cloning and characterization of a novel human histone deacetylase, HDAC8","volume":"350 Pt 1","author":"Buggy","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116972_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-5793(00)01813-5","article-title":"Cloning and characterization of human histone deacetylase 8","volume":"478","author":"Van Den Wyngaert","year":"2000","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.ejmech.2024.116972_bib27","doi-asserted-by":"crossref","first-page":"21568","DOI":"10.1074\/jbc.M117.811026","article-title":"HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides","volume":"292","author":"Casta\u00f1eda","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/modpathol.2015.34","article-title":"Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma","volume":"28","author":"Wilmott","year":"2015","journal-title":"Mod. Pathol.: An Official Journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"10.1016\/j.ejmech.2024.116972_bib29","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.drudis.2015.01.007","article-title":"Histone deacetylases: structural determinants of inhibitor selectivity","volume":"20","author":"Micelli","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2024.116972_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/MCB.24.2.765-773.2004","article-title":"Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A","volume":"24","author":"Lee","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.116972_bib31","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3892\/ijo.2015.3182","article-title":"The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma","volume":"47","author":"Song","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2024.116972_bib32","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/jm400390r","article-title":"Discovery of the first histone deacetylase 6\/8 dual inhibitors","volume":"56","author":"Olson","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.molcel.2008.06.006","article-title":"Acetylation of smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeast","volume":"31","author":"Zhang","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2024.116972_bib34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1126\/science.1157880","article-title":"A molecular determinant for the establishment of sister chromatid cohesion","volume":"321","author":"\u00dcnal","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116972_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116972_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.stem.2015.08.004","article-title":"HDAC8 inhibition specifically targets inv(16) acute myeloid leukemic stem cells by restoring p53 acetylation","volume":"17","author":"Qi","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejmech.2024.116972_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/er.2008-0017","article-title":"Transcriptional control of energy homeostasis by the estrogen-related receptors","volume":"29","author":"Gigu\u00e8re","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejmech.2024.116972_bib38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1101\/gad.1871610","article-title":"The homeobox protein Prox1 is a negative modulator of ERR\u03b1\/PGC-1\u03b1 bioenergetic functions","volume":"24","author":"Charest-Marcotte","year":"2010","journal-title":"Gene Dev."},{"key":"10.1016\/j.ejmech.2024.116972_bib39","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1210\/me.2009-0441","article-title":"An acetylation switch modulates the transcriptional activity of estrogen-related receptor \u03b1","volume":"24","author":"Wilson","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejmech.2024.116972_bib40","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/MCB.23.2.607-619.2003","article-title":"The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain","volume":"23","author":"Durst","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.116972_bib41","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/glia.24065","article-title":"Histone\u2010deacetylase 8 drives the immune response and the growth of glioma","volume":"69","author":"Mormino","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.ejmech.2024.116972_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12964-018-0231-4","article-title":"Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6","volume":"16","author":"Vanaja","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2024.116972_bib43","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/acschembio.6b00396","article-title":"HDAC8 catalyzes the hydrolysis of long chain fatty acyl lysine","volume":"11","author":"Aramsangtienchai","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116972_bib44","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1021\/cb500492r","article-title":"An unbiased approach to identify endogenous substrates of \u201cHistone\u201d deacetylase 8","volume":"9","author":"Olson","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116972_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133302","article-title":"HDAC8, A potential therapeutic target for the treatment of malignant peripheral nerve sheath tumors (MPNST)","volume":"10","author":"Lopez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116972_bib46","doi-asserted-by":"crossref","first-page":"C288","DOI":"10.1152\/ajpcell.00102.2014","article-title":"Histone deacetylase 8 regulates cortactin deacetylation and contraction in smooth muscle tissues","volume":"307","author":"Li","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejmech.2024.116972_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1078-0432.CCR-08-0684","article-title":"Histone deacetylase 8 in neuroblastoma tumorigenesis","volume":"15","author":"Oehme","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116972_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lfs.2016.02.092","article-title":"Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer","volume":"151","author":"Hsieh","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.116972_bib49","doi-asserted-by":"crossref","DOI":"10.3892\/or.18.4.769","article-title":"Expression profile of class I histone deacetylases in human cancer tissues","author":"Nakagawa","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2024.116972_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115594","article-title":"Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?","volume":"258","author":"Amin","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib51","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1021\/acs.jmedchem.7b01447","article-title":"Structure-based design and biological characterization of selective histone deacetylase 8 (HDAC8) inhibitors with anti-neuroblastoma activity","volume":"60","author":"Heimburg","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib52","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1182\/blood-2012-07-441022","article-title":"SOX4 is a direct target gene of FRA-2 and induces expression of HDAC8 in adult T-cell leukemia\/lymphoma","volume":"121","author":"Higuchi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.116972_bib53","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1007\/s10620-013-2867-7","article-title":"The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma","volume":"58","author":"Wu","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejmech.2024.116972_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116945","article-title":"MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression","volume":"237","author":"Menbari","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.116972_bib55","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/s41418-018-0080-0","article-title":"A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment","volume":"25","author":"Shen","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2024.116972_bib56","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/onc.2012.81","article-title":"Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8","volume":"32","author":"Yan","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2024.116972_bib57","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3389\/fcell.2020.00844","article-title":"HDAC8: a promising therapeutic target for acute myeloid leukemia","volume":"8","author":"Spreafico","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2024.116972_bib58","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2020.11.001","article-title":"Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function","volume":"534","author":"Watters","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116972_bib59","first-page":"4134","volume":"103","author":"Liu","year":"2006"},{"key":"10.1016\/j.ejmech.2024.116972_bib60","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1038\/s41388-020-1337-x","article-title":"HDAC8 promotes the dissemination of breast cancer cells via AKT\/GSK-3\u03b2\/Snail signals","volume":"39","author":"An","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2024.116972_bib61","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/biom9120824","article-title":"Induction of apoptosis and autophagy in breast cancer cells by a novel HDAC8 inhibitor","volume":"9","author":"Chiu","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2024.116972_bib62","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/nar\/gkaa039","article-title":"HDAC8 cooperates with SMAD3\/4 complex to suppress SIRT7 and promote cell survival and migration","volume":"48","author":"Tang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2024.116972_bib63","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116972_bib64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13148-022-01228-4","article-title":"HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer","volume":"14","author":"Pantelaiou-Prokaki","year":"2022","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ejmech.2024.116972_bib65","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1371\/journal.pntd.0000412","article-title":"Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden","volume":"3","author":"Hotez","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116972_bib66","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","article-title":"Human schistosomiasis","volume":"368","author":"Gryseels","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116972_bib67","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0035-9203(02)90405-0","article-title":"Resistance of Schistosoma mansoni to praziquantel: is there a problem?","volume":"96","author":"Doenhoff","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2024.116972_bib68","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4269\/ajtmh.1999.60.932","article-title":"Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers","volume":"60","author":"Ismail","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2024.116972_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003645","article-title":"Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke schistosoma mansoni","volume":"9","author":"Marek","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2024.116972_bib70","first-page":"794","volume":"106","author":"Pierce","year":"2011"},{"key":"10.1016\/j.ejmech.2024.116972_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molbiopara.2009.06.001","article-title":"Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni","volume":"168","author":"Dubois","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2024.116972_bib72","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbrc.2008.10.090","article-title":"The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoni","volume":"377","author":"Oger","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116972_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102375","article-title":"Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors","volume":"298","author":"Saccoccia","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature11316","article-title":"HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle","volume":"489","author":"Deardorff","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116972_bib75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajmg.a.32016","article-title":"Descriptive epidemiology of Cornelia de Lange syndrome in Europe","volume":"146A","author":"Barisic","year":"2008","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmech.2024.116972_bib76","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/pro.3030","article-title":"Structural aspects of HDAC8 mechanism and dysfunction in Cornelia de Lange syndrome spectrum disorders","volume":"25","author":"Deardorff","year":"2016","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2024.116972_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2011.07.080","article-title":"Histone deacetylase activators: N-acetylthioureas serve as highly potent and isozyme selective activators for human histone deacetylase-8 on a fluorescent substrate","author":"Singh","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116972_bib78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11940-014-0287-4","article-title":"Current treatment and management of dystrophinopathies","volume":"16","author":"Goemans","year":"2014","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.ejmech.2024.116972_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710014","article-title":"A therapeutic perspective of HDAC8 in different diseases: an overview of selective inhibitors","volume":"23","author":"Fontana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116972_bib80","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm1479","article-title":"Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors","volume":"12","author":"Minetti","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2024.116972_bib81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13395-021-00273-6","article-title":"The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene","volume":"11","author":"Licandro","year":"2021","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.ejmech.2024.116972_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105750","article-title":"Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy","volume":"170","author":"Spreafico","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116972_bib83","doi-asserted-by":"crossref","first-page":"L175","DOI":"10.1152\/ajplung.00551.2017","article-title":"HDAC8 inhibition ameliorates pulmonary fibrosis","volume":"316","author":"Saito","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejmech.2024.116972_bib84","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1073\/pnas.0404603101","article-title":"Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor","volume":"101","author":"Vannini","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.116972_bib85","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.str.2004.04.012","article-title":"Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases","volume":"12","author":"Somoza","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2024.116972_bib86","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1021\/acs.biochem.6b01014","article-title":"Structural and functional influence of the glycine-rich loop G 302 GGGY on the catalytic tyrosine of histone deacetylase 8","volume":"55","author":"Porter","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2024.116972_bib87","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.drudis.2015.01.004","article-title":"How the flexibility of human histone deacetylases influences ligand binding: an overview","volume":"20","author":"Deschamps","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2024.116972_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911775","article-title":"Methionine 274 is not the determining factor for selective inhibition of histone deacetylase 8 (HDAC8) by L-shaped inhibitors","volume":"23","author":"Jansch","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116972_bib89","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2008.9","article-title":"A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas","volume":"22","author":"Balasubramanian","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2024.116972_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmcr.2022.100097","article-title":"Targeting cancers and metabolic disorders: the prospects of combining HDAC8 inhibitor and activator","volume":"7","author":"Yusif","year":"2023","journal-title":"European Journal of Medicinal Chemistry Reports"},{"key":"10.1016\/j.ejmech.2024.116972_bib91","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1016\/j.bmcl.2007.02.064","article-title":"Design and evaluation of \u2018Linkerless\u2019 hydroxamic acids as selective HDAC8 inhibitors","volume":"17","author":"KrennHrubec","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116972_bib92","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.bmcl.2011.01.134","article-title":"Discovery of histone deacetylase 8 selective inhibitors","volume":"21","author":"Tang","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116972_bib93","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/cmdc.201200300","article-title":"Synthesis and biological evaluation of ortho \u2010aryl N \u2010hydroxycinnamides as potent histone deacetylase (HDAC) 8 isoform\u2010selective inhibitors","volume":"7","author":"Huang","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116972_bib94","doi-asserted-by":"crossref","first-page":"9562","DOI":"10.1021\/jm300837y","article-title":"Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries","volume":"55","author":"Suzuki","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib95","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1021\/acsmedchemlett.6b00239","article-title":"Development of a potent and selective HDAC8 inhibitor","volume":"7","author":"Ingham","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116972_bib96","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/acs.jmedchem.5b01478","article-title":"Structure-based design and synthesis of novel inhibitors targeting HDAC8 from schistosoma mansoni for the treatment of schistosomiasis","volume":"59","author":"Heinnburg","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib97","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/acsmedchemlett.7b00126","article-title":"Design, synthesis, and biological evaluation of tetrahydroisoquinoline-based histone deacetylase 8 selective inhibitors","volume":"8","author":"Taha","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116972_bib98","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejmech.2018.03.002","article-title":"Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors","volume":"150","author":"Zhao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib99","doi-asserted-by":"crossref","first-page":"8634","DOI":"10.1021\/acs.jmedchem.0c01025","article-title":"Characterization of conformationally constrained benzanilide scaffolds for potent and selective HDAC8 targeting","volume":"63","author":"Hassan","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib100","article-title":"Natural derivatives of selective HDAC8 inhibitors with PotentAntitumor efficacy against breast cancer","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib101","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cmdc.201500486","article-title":"Why hydroxamates may not Be the best histone deacetylase inhibitors\u2014what some may have forgotten or would rather forget?","volume":"11","author":"Shen","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116972_bib102","doi-asserted-by":"crossref","first-page":"16313","DOI":"10.1021\/acs.jmedchem.2c01132","article-title":"Development of alkylated hydrazides as highly potent and selective class I histone deacetylase inhibitors with T cell modulatory properties","volume":"65","author":"Sun","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib103","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.phrs.2018.03.001","article-title":"Structure-activity relationships of HDAC8 inhibitors: non-hydroxamates as anticancer agents","volume":"131","author":"Amin","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116972_bib104","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2174\/0929867033457089","article-title":"Design of \u03b2-lactams with mechanism based nonantibacterial activities","volume":"10","author":"Veinberg","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2008.03.047","article-title":"Anti-tumor activity of N-thiolated \u03b2-lactam antibiotics","volume":"268","author":"Chen","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2024.116972_bib106","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/cmdc.200900309","article-title":"Azetidinones as zinc\u2010binding groups to design selective HDAC8 inhibitors","volume":"4","author":"Galletti","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116972_bib107","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1016\/j.bmc.2011.06.030","article-title":"Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors","volume":"19","author":"Whitehead","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib108","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1016\/j.bmc.2016.09.022","article-title":"Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity","volume":"24","author":"Pidugu","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib109","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s10495-017-1410-2","article-title":"Novel histone deacetylase 8-selective inhibitor 1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer cells","volume":"22","author":"Pidugu","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2024.116972_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103934","article-title":"Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation","volume":"100","author":"Upadhyay","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib111","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/14756366.2020.1870457","article-title":"Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors","volume":"36","author":"Chen","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib112","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1021\/jm5008209","article-title":"ST7612AA1, a thioacetate-\u03c9(\u03b3-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors","volume":"57","author":"Giannini","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib113","doi-asserted-by":"crossref","first-page":"72373","DOI":"10.1039\/C5RA12606A","article-title":"Design of dual MMP-2\/HDAC-8 inhibitors by pharmacophore mapping, molecular docking, synthesis and biological activity","volume":"5","author":"Halder","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116972_bib114","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2147\/DDDT.S124977","article-title":"Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs","volume":"11","author":"Wang","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2024.116972_bib115","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/cmdc.201600528","article-title":"Potent and selective non\u2010hydroxamate histone deacetylase 8 inhibitors","volume":"11","author":"Kleinschek","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116972_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111756","article-title":"Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors","volume":"184","author":"Wolff","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib117","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd2155","article-title":"Why is cancer drug discovery so difficult?","volume":"6","author":"Kamb","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116972_bib118","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116972_bib119","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13148-016-0271-9","article-title":"Epigenetic polypharmacology: from combination therapy to multitargeted drugs","volume":"8","author":"de Lera","year":"2016","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ejmech.2024.116972_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112904","article-title":"Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors","volume":"209","author":"Bass","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106622","article-title":"Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: structure, function and design","volume":"138","author":"Peng","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib122","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/emmm.201201923","article-title":"Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease","volume":"5","author":"Govindarajan","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2024.116972_bib123","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1021\/jm401225q","article-title":"Synthesis and structure\u2013activity relationship of 3-Hydroxypyridine-2-thione-Based histone deacetylase inhibitors","volume":"56","author":"Sodji","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib124","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1021\/jm5008962","article-title":"Identification of a novel aminotetralin class of HDAC6 and HDAC8 selective inhibitors","volume":"57","author":"Tang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acs.jmedchem.5b01525","article-title":"Design, synthesis, and pharmacological evaluation of novel N -acylhydrazone derivatives as potent histone deacetylase 6\/8 dual inhibitors","volume":"59","author":"Rodrigues","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib126","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.ejmech.2017.10.076","article-title":"The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6\/HDAC8 selectivity","volume":"143","author":"Negmeldin","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib127","article-title":"Discovery of novel potential selective HDAC8 inhibitors by combine ligand-based, structure-based virtual screening and in-vitro biological evaluation","volume":"9","author":"Debnath","year":"2019","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.ejmech.2024.116972_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114409","article-title":"Azetidin-2-one-based small molecules as dual hHDAC6\/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability","volume":"238","author":"Federico","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib129","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1183\/09031936.00095113","article-title":"Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice","volume":"43","author":"Sanders","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2024.116972_bib130","doi-asserted-by":"crossref","first-page":"10528","DOI":"10.1021\/acs.jmedchem.3c00644","article-title":"Discovery of HDAC6, HDAC8, and 6\/8 inhibitors and development of cell-based drug screening models for the treatment of TGF-\u03b2-induced idiopathic pulmonary fibrosis","volume":"66","author":"Yu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib131","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1002\/ctm2.154","article-title":"Natural HDAC\u20101\/8 inhibitor baicalein exerts therapeutic effect in CBF\u2010AML","volume":"10","author":"Yu","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejmech.2024.116972_bib132","doi-asserted-by":"crossref","first-page":"11748","DOI":"10.1021\/jf303261r","article-title":"Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis","volume":"60","author":"Sun","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib133","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1471-2407-12-180","article-title":"Plant HDAC inhibitor chrysin arrest cell growth and induce p21 WAF1 by altering chromatin of STAT response element in A375 cells","volume":"12","author":"Pal-Bhadra","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2024.116972_bib134","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1021\/jm2001025","article-title":"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes","volume":"54","author":"Neelarapu","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/med.21600","article-title":"Epigenetic polypharmacology: a new frontier for epi\u2010drug discovery","volume":"40","author":"Tomaselli","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.116972_bib136","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1535-7163.MCT-13-0791","article-title":"Targeting microtubules by natural agents for cancer therapy","volume":"13","author":"Mukhtar","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2024.116972_bib137","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/jm900321u","article-title":"Iso combretastatins A versus combretastatins A: the forgotten iso CA-4 isomer as a highly promising cytotoxic and antitubulin agent","volume":"52","author":"Messaoudi","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib138","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1021\/acs.jmedchem.8b00050","article-title":"Design and synthesis of tubulin and histone deacetylase inhibitor based on iso-combretastatin A-4","volume":"61","author":"Lamaa","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112338","article-title":"Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6\/8 and bromodomain BRPF1","volume":"200","author":"Ghazy","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.apsb.2023.09.003","article-title":"Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies","volume":"14","author":"Peng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2024.116972_bib141","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2024.116972_bib142","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116972_bib143","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1021\/acs.jmedchem.2c00739","article-title":"Structure-based discovery of selective histone deacetylase 8 degraders with potent anticancer activity","volume":"66","author":"Huang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114544","article-title":"Discovery of pomalidomide-based PROTACs for selective degradation of histone deacetylase 8","volume":"239","author":"Sun","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib145","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1039\/D2CC00272H","article-title":"Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC)","volume":"58","author":"Chotitumnavee","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.116972_bib146","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.3390\/ijms23147535","article-title":"Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity","volume":"23","author":"Darwish","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116972_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106546","article-title":"Discovery of highly potent HDAC8 PROTACs with anti-tumor activity","volume":"136","author":"Zhao","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib148","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.chembiol.2023.07.010","article-title":"HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation","volume":"30","author":"Xiao","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116972_bib149","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c00761","article-title":"Discovery of a highly potent and selective HDAC8 degrader: advancing the functional understanding and therapeutic potential of HDAC8","author":"Xiao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/acsmedchemlett.2c00436","article-title":"Phenyl dihydrouracil: an alternative cereblon binder for PROTAC design","volume":"14","author":"Jarusiewicz","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116972_bib151","article-title":"Exploration of hydrazide-based HDAC8 PROTACs for the treatment of hematological malignancies and solid tumors","author":"Zhao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib152","doi-asserted-by":"crossref","first-page":"10917","DOI":"10.1021\/acs.jmedchem.3c00736","article-title":"Small-molecule hydrophobic tagging: a promising strategy of druglike technology for targeted protein degradation","volume":"66","author":"Xie","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib153","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/1062936X.2017.1375978","article-title":"Novel HDAC8 inhibitors: a multi-computational approach","volume":"28","author":"Manal","year":"2017","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.ejmech.2024.116972_bib154","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4155\/fmc-2018-0005","article-title":"Diverse classes of HDAC8 inhibitors: in search of molecular fingerprints that regulate activity","volume":"10","author":"Amin","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116972_bib155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/1062936X.2020.1723136","article-title":"Discriminations of active from inactive HDAC8 inhibitors part II: Bayesian classification study to find molecular fingerprints","volume":"31","author":"Amin","year":"2020","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.ejmech.2024.116972_bib156","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1080\/07391102.2019.1617782","article-title":"Structural exploration of tetrahydroisoquinoline derivatives as HDAC8 inhibitors through multi-QSAR modeling study","volume":"38","author":"Banerjee","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2024.116972_bib157","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1080\/07391102.2019.1704881","article-title":"Essential elements regulating HDAC8 inhibition: a classification based structural analysis and enzyme-inhibitor interaction study of hydroxamate based HDAC8 inhibitors","volume":"38","author":"Banerjee","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2024.116972_bib158","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/1062936X.2022.2155241","article-title":"A comparative quantitative structural assessment of benzothiazine-derived HDAC8 inhibitors by predictive ligand-based drug designing approaches","volume":"33","author":"Banerjee","year":"2022","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.ejmech.2024.116972_bib159","doi-asserted-by":"crossref","DOI":"10.2174\/0115734064320232240709105228","article-title":"Crucial structural understanding for selective HDAC8 inhibition: common pharmacophores, molecular docking, molecular dynamics, andZinc binder analysis of selective HDAC8 inhibitors","volume":"20","author":"Sarkar","year":"2024","journal-title":"Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T01:25:21Z","timestamp":1732152321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424008535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":159,"alternative-id":["S0223523424008535"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116972","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC8 as a target in drug discovery: Function, structure and design","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116972"}}